Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 3.34
0.3 %
$ 420 M
Market Cap
-66.8
P/E
ORGO - STOCK-BASED COMPENSATION
Stock-based Compensation ORGO - Organogenesis Holdings Inc.
9 M
LAST VALUE
52.58%
2 YEAR CAGR
52.94%
5 YEAR CAGR
0.00%
10 YEAR CAGR